Literature DB >> 15771276

Tissue ablation with irreversible electroporation.

R V Davalos1, I L M Mir, B Rubinsky.   

Abstract

This study introduces a new method for minimally invasive treatment of cancer-the ablation of undesirable tissue through the use of irreversible electroporation. Electroporation is the permeabilization of the cell membrane due to an applied electric field. As a function of the field amplitude and duration, the permeabilization can be reversible or irreversible. Over the last decade, reversible electroporation has been intensively pursued as a very promising technique for the treatment of cancer. It is used in combination with cytotoxic drugs, such as bleomycin, in a technique known as electrochemotherapy. However, irreversible electroporation was completely ignored in cancer therapy. We show through mathematical analysis that irreversible electroporation can ablate substantial volumes of tissue, comparable to those achieved with other ablation techniques, without causing any detrimental thermal effects and without the need of adjuvant drugs. This study suggests that irreversible electroporation may become an important and innovative tool in the armamentarium of surgeons treating cancer.

Entities:  

Mesh:

Year:  2005        PMID: 15771276     DOI: 10.1007/s10439-005-8981-8

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  320 in total

1.  TASER electronic control devices and eye injuries.

Authors:  Mark W Kroll; Donald M Dawes; William G Heegaard
Journal:  Doc Ophthalmol       Date:  2012-01-13       Impact factor: 2.379

2.  Real-time ultrasound imaging of irreversible electroporation in a porcine liver model adequately characterizes the zone of cellular necrosis.

Authors:  Carl R Schmidt; Peter Shires; Mary Mootoo
Journal:  HPB (Oxford)       Date:  2011-11-16       Impact factor: 3.647

3.  Magnetic resonance imaging characteristics of nonthermal irreversible electroporation in vegetable tissue.

Authors:  Mohammad Hjouj; Boris Rubinsky
Journal:  J Membr Biol       Date:  2010-07-15       Impact factor: 1.843

4.  MR imaging to assess immediate response to irreversible electroporation for targeted ablation of liver tissues: preclinical feasibility studies in a rodent model.

Authors:  Yue Zhang; Yang Guo; Ann B Ragin; Robert J Lewandowski; Guang-Yu Yang; Grace M Nijm; Alan V Sahakian; Reed A Omary; Andrew C Larson
Journal:  Radiology       Date:  2010-08       Impact factor: 11.105

5.  Robustness of treatment planning for electrochemotherapy of deep-seated tumors.

Authors:  Bor Kos; Anze Zupanic; Tadej Kotnik; Marko Snoj; Gregor Sersa; Damijan Miklavcic
Journal:  J Membr Biol       Date:  2010-07-02       Impact factor: 1.843

6.  Nanoelectroablation therapy for murine basal cell carcinoma.

Authors:  Richard Nuccitelli; Saleh Sheikh; Kevin Tran; Brian Athos; Mark Kreis; Pamela Nuccitelli; Kris S Chang; Ervin H Epstein; Jean Y Tang
Journal:  Biochem Biophys Res Commun       Date:  2012-07-04       Impact factor: 3.575

Review 7.  Lung cancer ablation: what is the evidence?

Authors:  Thierry de Baere; Geoffroy Farouil; Frederic Deschamps
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

Review 8.  Irreversible electroporation of hepatic malignancy.

Authors:  Govindarajan Narayanan; Tatiana Froud; Rekhaben Suthar; Katuska Barbery
Journal:  Semin Intervent Radiol       Date:  2013-03       Impact factor: 1.513

Review 9.  Lung cancer ablation: technologies and techniques.

Authors:  Erica S Alexander; Damian E Dupuy
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

Review 10.  Advances in managing hepatocellular carcinoma.

Authors:  Marielle Reataza; David K Imagawa
Journal:  Front Med       Date:  2014-05-08       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.